Zacks Research Downgrades Option Care Health (NASDAQ:OPCH) to Strong Sell

Option Care Health (NASDAQ:OPCH) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Monday,Zacks.com reports.

Several other analysts have also commented on the stock. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research report on Tuesday, January 13th. UBS Group reduced their price objective on Option Care Health from $45.00 to $39.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Morgan Stanley set a $28.00 price objective on Option Care Health in a research report on Wednesday, May 6th. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 target price on the stock. in a report on Friday, May 1st. Finally, Stephens set a $30.00 price target on shares of Option Care Health in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $31.25.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $19.59 on Monday. The firm has a market capitalization of $3.08 billion, a price-to-earnings ratio of 15.19, a price-to-earnings-growth ratio of 1.10 and a beta of 0.68. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The business’s 50 day simple moving average is $27.52 and its 200-day simple moving average is $30.43. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s revenue was up 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities analysts forecast that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Option Care Health news, Director Timothy P. Sullivan purchased 24,154 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were acquired at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the purchase, the director owned 73,383 shares in the company, valued at $1,518,294.27. The trade was a 49.06% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, with a total value of $783,820.10. Following the acquisition, the director directly owned 450,000 shares of the company’s stock, valued at $9,634,500. The trade was a 8.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 73,264 shares of company stock worth $1,548,316 over the last ninety days. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Van Berkom & Associates Inc. acquired a new position in shares of Option Care Health in the 1st quarter valued at approximately $42,739,000. Dimensional Fund Advisors LP increased its stake in shares of Option Care Health by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after buying an additional 36,208 shares during the last quarter. KBC Group NV raised its holdings in Option Care Health by 22.1% in the first quarter. KBC Group NV now owns 5,453 shares of the company’s stock valued at $147,000 after acquiring an additional 988 shares in the last quarter. Jennison Associates LLC boosted its stake in Option Care Health by 4.2% during the 1st quarter. Jennison Associates LLC now owns 1,213,025 shares of the company’s stock valued at $32,655,000 after acquiring an additional 49,094 shares during the last quarter. Finally, Bessemer Group Inc. boosted its stake in Option Care Health by 2,109.5% during the 1st quarter. Bessemer Group Inc. now owns 20,526 shares of the company’s stock valued at $553,000 after acquiring an additional 19,597 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.